Immune

GSK outlines ambitious 10-year plan, but hits investors' near-term outlook
BioPharma Dive
Wed, 06/23/21 - 10:29 pm
GSK
investors
cancer
Immune
infectious disease
Rogue Immune Cells Tied to MS Point to New Drug Target
Bloomberg
Wed, 01/30/13 - 06:07 pm
Immune
Drug